Specific self-antigen-driven immune response in pericardial effusion as an isolated GVHD manifestation

被引:8
作者
Lev, A. [1 ,2 ]
Amariglio, N. [1 ,2 ,3 ]
Spirer, Z. [2 ,4 ]
Katz, U. [2 ,5 ]
Bielorai, B. [2 ,6 ]
Rechavi, G. [1 ,2 ]
Somech, R. [1 ,2 ,4 ]
机构
[1] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel
[2] Sackler Sch Med, Tel Aviv, Israel
[3] Chaim Sheba Med Ctr, Hematol Lab, IL-52621 Tel Hashomer, Israel
[4] Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Immunol Serv, Tel Hashomer, Israel
[5] Safra Childrens Hosp, Chaim Sheba Med Ctr, E Safra Congenital Heart Dis Ctr, Pediat Cardiol Clin, Tel Hashomer, Israel
[6] Safra Childrens Hosp, Chaim Sheba Med Ctr, Bone Marrow Transplantat Unit, Pediat Hematol Oncol Div, Tel Hashomer, Israel
关键词
GVHD; pericardial effusion; tamponade; thymus; TCR; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; CARDIAC-TAMPONADE; IMMUNODEFICIENCY; PATIENT;
D O I
10.1038/bmt.2009.314
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Pericardial effusion and cardiac tamponade have been described as GVHD manifestations in the post transplant period. Direct evidence of GVHD-related TCR or B-cell receptor clones in patients with pericardial effusion has never been described. Using several methods, including FACS and spectratyping analysis to assess T- and B-cell clonality and to quantify TCR excision circles to assess newly thymus-derived T cells, we were able to show expansion of oligoclonal T-cell populations and the possible presence of early/premature B cells in the pericardial effusion but not in peripheral mononuclear cells. This may explain the presentation of an isolated GVHD manifestation. Bone Marrow Transplantation (2010) 45, 1084-1087; doi:10.1038/bmt.2009.314; published online 16 November 2009
引用
收藏
页码:1084 / 1087
页数:4
相关论文
共 14 条
[1]   SUDDEN CARDIAC-TAMPONADE AFTER CHEMOTHERAPY FOR MARROW TRANSPLANTATION IN THALASSEMIA [J].
ANGELUCCI, E ;
MARIOTTI, E ;
LUCARELLI, G ;
BARONCIANI, D ;
CESARONI, P ;
DURAZZI, SMT ;
GALIMBERTI, M ;
GIARDINI, C ;
MURETTO, P ;
POLCHI, P ;
SGARBI, E .
LANCET, 1992, 339 (8788) :287-289
[2]   Newborn screening for severe combined immunodeficiency (SCID): A review [J].
Huang, H ;
Manton, KG .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :1024-1039
[3]   Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL [J].
Ivanov, V ;
Faucher, C ;
Bilger, K ;
Vey, N ;
Sainty, D ;
Calmels, B ;
Chabannon, C ;
Lafage-Pochitaloff, M ;
Mozziconacci, MJ ;
Mohty, M ;
Chrestian, MA ;
Blaise, D .
BONE MARROW TRANSPLANTATION, 2003, 32 (09) :961-963
[4]  
O'Keefe Christine L, 2004, Hematology, V9, P189, DOI 10.1080/10245330410001701530
[5]   Role of type IINKT cells in the suppression of graft-versus-host disease [J].
Oh, Sae Jin ;
Kim, Ji Hyung ;
Min, Chang Ki ;
Chung, Doo Hyun .
CRITICAL REVIEWS IN IMMUNOLOGY, 2008, 28 (03) :249-267
[6]  
Pérez-Simón JA, 2006, DRUGS, V66, P1041
[7]   Pericardial effusion and cardiac tamponade in pediatric stem cell transplant recipients [J].
Rhodes, M ;
Lautz, T ;
Kavanaugh-Mchugh, A ;
Manes, B ;
Calder, C ;
Koyama, T ;
Liske, M ;
Parra, D ;
Frangoul, H .
BONE MARROW TRANSPLANTATION, 2005, 36 (02) :139-144
[8]   Pericardial graft vs. host disease in a patient with myelodysplastic syndrome following peripheral blood stem cell transplantation [J].
Saito, Y ;
Matsushima, T ;
Doki, N ;
Tsumita, Y ;
Takizawa, M ;
Yokohama, A ;
Handa, H ;
Tsukamoto, N ;
Karasawa, M ;
Murakami, H ;
Nojima, Y .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 (01) :65-67
[9]  
Seber A, 1996, BONE MARROW TRANSPL, V17, P207
[10]   Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion [J].
Silberstein, L ;
Davies, A ;
Kelsey, S ;
Foran, J ;
Murrell, C ;
D'Cruz, D ;
Vinnicombe, S ;
Norton, A ;
Cavenagh, J .
BONE MARROW TRANSPLANTATION, 2001, 27 (02) :231-233